• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
  • Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Ending the HIV epidemic: Finding new insights with EHR data

Ending the HIV epidemic: Finding new insights with EHR data

by Truveta staff | Apr 18, 2024 | Data

In 2019, the US government unveiled the ambitious Ending the HIV Epidemic (EHE) plan, aiming to slash new HIV infections by 90% by 2030. Thanks to advances in antiretroviral therapy (ART), proven models of prevention, and data access, new HIV infections declined 12%...
Truveta wins SXSW Innovation Award for Artificial Intelligence

Truveta wins SXSW Innovation Award for Artificial Intelligence

by Truveta staff | Mar 13, 2024 | News, Technology

Truveta has won the 2024 South by Southwest Innovation Award in Artificial Intelligence for its AI-enabled health research and the Truveta Language Model (TLM). TLM is a large-language, multi-modal AI model for transforming electronic health record (EHR) data into...
Crohn’s disease and the power of complete, timely, and clean EHR data

Crohn’s disease and the power of complete, timely, and clean EHR data

by Truveta staff | Jan 18, 2024 | Data

Crohn’s disease, a complex chronic inflammatory disorder of the GI tract, affects approximately 780,000 Americans with an estimated 33,000 new cases diagnosed each year. Crohn’s, along with ulcerative colitis, are the two major forms of inflammatory bowel disease...
Truveta showcases the power of real-world data from EHRs at October events

Truveta showcases the power of real-world data from EHRs at October events

by Truveta staff | Nov 1, 2023 | Data

October was a whirlwind month for Truveta, marked by participation in various conferences across the United States. In the span of less than 10 days, Truveta experts and customers presented at four different events, showcasing how Truveta Data is being used to enable...
Liver Disease Statistics & Insights: Leveraging Truveta Data for Research

Liver Disease Statistics & Insights: Leveraging Truveta Data for Research

by Truveta staff | Oct 26, 2023 | Data

Hidden under the surface of daily life, a disease often referred to as a “silent killer” is slowly taking hold over millions of Americans. While approximately 4.5M US adults have received a diagnosis of liver disease, a far larger yet largely unaware group is treading...
« Older Entries
Next Entries »

Share this


Recent posts

  • ASCO 2025: Development and validation of machine learning risk prediction models for detection of early-onset colorectal cancer
  • ASCO 2025: Changes in colorectal cancer screening and detection following USPSTF expanded recommendations
  • Prostate cancer is in the headlines — and early detection has never been more important

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice